Pulmonx Corp (LUNG) › Cost of RevenuePulmonx Corp (LUNG) — Cost of RevenueAnnual figures by period end, from SEC filings.2018-12-31: $7.72M2019-12-31: $10.18M2020-12-31: $11.53M2021-12-31: $12.79M2022-12-31: $13.80M2023-12-31: $17.92M2024-12-31: $21.79M2025-12-31: $23.36M$23.36M2018-12-31Cost of Revenue (USD)2025-12-31Period endedCost of RevenueChange YoYSource filing2025-12-31$23.36M+7.2%2026-03-10From 2025-01-012024-12-31$21.79M+21.6%2026-03-10From 2024-01-012023-12-31$17.92M+29.9%2025-02-25From 2023-01-012022-12-31$13.80M+7.9%2024-02-27From 2022-01-012021-12-31$12.79M+10.9%2023-03-01From 2021-01-012020-12-31$11.53M+13.3%2022-03-01From 2020-01-012019-12-31$10.18M+31.9%2021-03-15From 2019-01-012018-12-31$7.72M—2021-03-15From 2018-01-01Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)